Donald E. Moss

1.5k total citations
55 papers, 1.2k citations indexed

About

Donald E. Moss is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Donald E. Moss has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 24 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Donald E. Moss's work include Cholinesterase and Neurodegenerative Diseases (22 papers), Neuroscience and Neuropharmacology Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Donald E. Moss is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (22 papers), Neuroscience and Neuropharmacology Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Donald E. Moss collaborates with scholars based in United States, United Kingdom and Japan. Donald E. Moss's co-authors include Miriam Hagan, Isabel C. Sumaya, Joseph Rogers, Ruth G. Perez, David Fahrney, S.B. McMaster, Rebecca Palacios, Thomas L. Bennett, Richard L. Johnson and Beth Menees Rienzi and has published in prestigious journals such as Nature, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Donald E. Moss

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald E. Moss United States 20 434 424 247 225 224 55 1.2k
Kornélia Tekes Hungary 26 467 1.1× 468 1.1× 461 1.9× 198 0.9× 81 0.4× 129 1.8k
R.M. Tordera Spain 30 303 0.7× 909 2.1× 631 2.6× 429 1.9× 123 0.5× 51 3.0k
Sylvain Roux France 15 224 0.5× 732 1.7× 519 2.1× 265 1.2× 86 0.4× 29 1.9k
E K Perry United Kingdom 13 331 0.8× 533 1.3× 426 1.7× 350 1.6× 31 0.1× 23 1.8k
Claudia Fracasso Italy 25 366 0.8× 927 2.2× 575 2.3× 289 1.3× 107 0.5× 55 2.0k
Shai Shoham Israel 20 377 0.9× 288 0.7× 420 1.7× 238 1.1× 135 0.6× 35 1.3k
Yumi Sugimoto Japan 21 248 0.6× 641 1.5× 489 2.0× 254 1.1× 220 1.0× 98 1.5k
Jacques Simiand France 23 382 0.9× 1.3k 3.0× 713 2.9× 233 1.0× 285 1.3× 32 2.7k
K. Rasmussen United States 20 304 0.7× 1.3k 3.2× 998 4.0× 330 1.5× 125 0.6× 28 2.1k
Kazushige Mizoguchi Japan 24 211 0.5× 548 1.3× 520 2.1× 367 1.6× 127 0.6× 77 2.6k

Countries citing papers authored by Donald E. Moss

Since Specialization
Citations

This map shows the geographic impact of Donald E. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Moss more than expected).

Fields of papers citing papers by Donald E. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald E. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Moss. The network helps show where Donald E. Moss may publish in the future.

Co-authorship network of co-authors of Donald E. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Donald E. Moss. A scholar is included among the top collaborators of Donald E. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald E. Moss. Donald E. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orfila, James E., et al.. (2014). Cholinergic Transmission during Nicotine Withdrawal Is Influenced by Age and Pre-Exposure to Nicotine: Implications for Teenage Smoking. Developmental Neuroscience. 36(3-4). 347–355. 8 indexed citations
2.
Moss, Donald E., et al.. (2012). A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease. British Journal of Clinical Pharmacology. 75(5). 1231–1239. 11 indexed citations
3.
Santiago, Mario L., et al.. (2007). In utero methanesulfonyl fluoride differentially affects learning and maze performance in the absence of long-lasting cholinergic changes in the adult rat. Pharmacology Biochemistry and Behavior. 88(4). 374–384. 2 indexed citations
4.
Irwin, Louis N., et al.. (2005). Prenatal exposure to the acetylcholinesterase inhibitor methanesulfonyl fluoride alters forebrain morphology and gene expression. Developmental Brain Research. 158(1-2). 13–22. 14 indexed citations
5.
Borlongan, Cesar V., Isabel C. Sumaya, & Donald E. Moss. (2005). Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats. Brain Research. 1038(1). 50–58. 26 indexed citations
6.
Sumaya, Isabel C., et al.. (2004). Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats. Pharmacology Biochemistry and Behavior. 78(4). 727–733. 13 indexed citations
7.
Sumaya, Isabel C., et al.. (2001). Bright Light Treatment Decreases Depression in Institutionalized Older Adults: A Placebo-Controlled Crossover Study. The Journals of Gerontology Series A. 56(6). M356–M360. 78 indexed citations
8.
9.
Hagan, Miriam, et al.. (1997). Combined Naloxone and Fluoxetine on Deprivation-Induced Binge Eating of Palatable Foods in Rats. Pharmacology Biochemistry and Behavior. 58(4). 1103–1107. 26 indexed citations
10.
Hagan, Michael P. & Donald E. Moss. (1995). Effect of peptide YY (PYY) on food-associated conflict1. Physiology & Behavior. 58(4). 731–735. 20 indexed citations
11.
Hagan, Miriam & Donald E. Moss. (1994). Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia. Peptides. 15(2). 243–245. 12 indexed citations
12.
Hagan, Miriam & Donald E. Moss. (1993). Suppression of peptide YY-induced hyperphagia by terbutaline. Pharmacology Biochemistry and Behavior. 46(3). 679–681. 11 indexed citations
13.
Palacios, Rebecca, et al.. (1993). Methanesulfonyl fluoride (MSF) blocks scopolamine-induced amnesia in rats. Neurobiology of Aging. 14(1). 93–96. 3 indexed citations
14.
Malin, David H., et al.. (1993). Chronic methanesulfonyl fluoride enhances one-trial per day reward learning in aged rats. Neurobiology of Aging. 14(4). 393–395. 10 indexed citations
15.
Moss, Donald E., et al.. (1991). Simple spectrophotometric assay for calcium-activated neutral proteases (calpains). Pharmacology Biochemistry and Behavior. 39(2). 495–497. 11 indexed citations
16.
Castañeda, Edward, Donald E. Moss, Scott Oddie, & Ian Q. Whishaw. (1991). THC does not affect striatal dopamine release: Microdialysis in freely moving rats. Pharmacology Biochemistry and Behavior. 40(3). 587–591. 42 indexed citations
17.
Malin, David H., et al.. (1991). Methanesulfonyl fluoride enhances one-trial reward learning in mid-aged rats. Neurobiology of Aging. 12(2). 181–183. 8 indexed citations
18.
Moss, Donald E., et al.. (1989). Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of tourette syndrome and other motor disorders. Life Sciences. 44(21). 1521–1525. 37 indexed citations
19.
Moss, Donald E., et al.. (1985). Comparative behavioral effects of CNS cholinesterase inhibitors. Pharmacology Biochemistry and Behavior. 22(3). 479–482. 10 indexed citations
20.
Clark, Stephen J., Donald E. Moss, & D. Bray. (1983). Actin polymerization and synthesis in cultured neurones. Experimental Cell Research. 147(2). 303–314. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kornélia Tekes Breakdown of academic impact, for papers by R.M. Tordera Breakdown of academic impact, for papers by Sylvain Roux Breakdown of academic impact, for papers by E K Perry Breakdown of academic impact, for papers by Claudia Fracasso Breakdown of academic impact, for papers by Shai Shoham Breakdown of academic impact, for papers by Yumi Sugimoto Breakdown of academic impact, for papers by Jacques Simiand Breakdown of academic impact, for papers by K. Rasmussen Breakdown of academic impact, for papers by Kazushige Mizoguchi
Rankless by CCL
2026